Impilo

Stockholm, Sweden
Impilo is focused on healthcare investments in Nordic regions.

About Impilo

Impilo is a company based in Stockholm (Sweden). It operates as a Brokerage / Intermediation. Impilo has completed 11 acquisitions, including Decon, Euro Accident and Immedica. Impilo offers products and services including Healthcare Investments.

  • Headquarter Stockholm, Sweden
  • Sectors
    Financial Services
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website impilo.se
  • Social LinkedIn
Key Metrics
  • Investments & Acquisitions
    Decon

    & 10 more

Products & Services of Impilo

Impilo offers a comprehensive portfolio of products and services, including Healthcare Investments.

Healthcare Investments
Investment Services

Investments in healthcare companies are managed and supported.

Investments & Acquisitions by Impilo

Impilo has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Decon, Euro Accident and Immedica.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Develops medical devices for cochlear implants and bone conduction hearing aids.
oticonmedical.comGothenburg, Sweden2009Oct 2025••••
Bowel and urology care products are supplied for health management.
qufora.comLyngby, Denmark2006Sep 2024••••
Therapeutic agents for oncology, neurology, and related diseases are developed.
immedica.comStockholm, Sweden2017Apr 2024••••
A chain of general clinics is operated in Sweden.
vaccindirekt.seStockholm, Sweden2003Aug 2023••••
Electric wheelchair design services are provided by Decon in Sweden.
decon.seHyltebruk, Sweden2002Jun 2023••••
Temperature-controlled storage units are manufactured by Lowenco for cold facilities.
lowenco.comVamdrup, Denmark2012Feb 2022••••
A chain of dental clinics is operated in Denmark.
tandlaegen.dkLyngby, Denmark2016Nov 2021••••
Proider of multiple insurance solutions
euroaccident.comDanderyd, Sweden1996Aug 2019$138M
Chain of fertility clinics
thefertilitypartnership.comOxford, United Kingdom2015Mar 2019••••
Personalized fertility treatments and support are provided by European clinics.
tfp-fertility.comOxford, United Kingdom1979Mar 2019••••
Premium access

Complete acquisition details for Impilo

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Impilo

10 dated milestones of Impilo across 6 years, from founding to its latest funding, stage changes and deals.

  1. Acquisition Acquires TFP.
  2. Acquisition Acquires The Fertility Partnership.
  3. Acquisition Acquires Euro Accident.
  4. Acquisition Acquires tandlægen.dk.
  5. Acquisition Acquires Lowenco.
  6. Acquisition Acquires Decon.
  7. Acquisition Acquires Vaccine Direct.
  8. Acquisition Acquires Immedica.
  9. Acquisition Acquires Qufora.
  10. Acquisition Acquires Oticon Medical.

Similar companies to Impilo

10 companies that operate in the same segment as Impilo (Healthcare Financing Solutions), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Operates an online platform for personal loans to individuals.
2018Hyderabad, Telangana, India–USD 76.96 K–
A conglomerate with diversified interests in property and finance.
1963Kuala Lumpur, Malaysia–USD 465.74 M–
Offers an app-based platform for accessing personal loans.
2019India–––
Private equity firm investing in tech innovations and startups in India and South-East Asia.
2015Singapore, Singapore–––
Financial and technology solutions are provided for the agricultural industry.
2014Oregon City, Oregon, United StatesUSD 200 K––
Hosts a digital marketplace to facilitate healthcare financing solutions.
2016Pune, Maharashtra, IndiaUSD 618.76 KUSD 143.8 K9
Hosts a digital marketplace for healthcare loans.
2017Delhi, Delhi, IndiaUSD 818.41 KUSD 89.47 K–
An online platform specializing in gold loans for quick and secure lending services.
2018Gurugram, Haryana, India–USD 5.65 M611
Serves as a loan comparison platform for users.
2019Gurugram, Haryana, India–USD 291.22 K5
Provides financing for exercising ESOPs with tax-efficient, hassle-free loans.
2021Andheri, Maharashtra, IndiaUSD 1.49 MUSD 258.3 K1
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Impilo

Impilo is headquartered in Stockholm, Sweden.

Impilo is engaged as a Nordic investment company specializing in the healthcare sector. Investments are made in pharmaceutical, medtech, specialist pharma services, and related healthcare industries. Portfolio companies are supported to ensure sustainable development within their markets. The focus is placed on positive health impacts and sustainability of healthcare systems. Target companies are evaluated based on their potential to improve quality of care, increase availability, lower costs, and prevent the need for care. Investments are structured to double operating profits over five years while outperforming relevant markets.

Impilo offers Healthcare Investments.

Impilo has made 11 acquisitions, including Decon, Euro Accident, and Immedica.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available